BrightPath Biotherapeutics
4594.TTSE GROWTHPharmaceutical
Filed as BrightPath Biotherapeutics Co., Ltd (2022-06–2026-06)
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 4
| Phillip Securities Japan, Ltd. | 4.88% |
| Evo Fund | 4.62% |
| Macquarie Bank Limited | 1.84% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 51
| Holder | Ratio | Change |
|---|---|---|
| Evo Fund2024-07-12 · amended | 17.29% | -1.90pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 19.19% | -0.94pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 20.13% | -1.02pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 21.15% | -1.08pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 22.23% | -1.02pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 23.25% | -1.02pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 24.27% | -0.72pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 24.99% | -1.18pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 26.17% | -1.04pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 27.21% | -1.16pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.